Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
(NASDAQ:IBIO), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today ...
Naples Comprehensive Health (NCH) today announced plans to expand its premier cardiovascular service to include the foundation of an Advanced Heart Failure and Transplant program, reinforcing its ...
Milestone procedure gives young father with advanced heart failure a new heart and new future with his family.
Segment showcases SynCardia Total Artificial Heart supporting patients with advanced heart failure and next-generation development programs ...
Achieving remission from prediabetes dramatically reduces the risk of heart disease and other major cardiovascular events.
Farrah Fawcett and Ryan O'Neal’s son Redmond O'Neal had a lengthy string of legal issues before showing up in court with ...
Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026 Initiated global ...
Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026 Initiated global Phase 3 LEVEL-2 clinical trial and opened long-term OLE study for patients ...
The number of Australians treated for kidney failure, including dialysis, over the past two decades has doubled to 2.7 ...
Cardiovascular disease is the leading cause of death in North Carolina, and effective management of the condition is essential to improving residents’ quality of life. Cardiovascular conditions are a ...
Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results